These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 9925232)

  • 41. [Gabapentin in 50 patients with epilepsy].
    Gracia-Fleta F; Medrano-Martínez V; Castaño-Pérez MD; Hernández-Lorido R; Mañes R
    Rev Neurol; 2001 Jan 1-15; 32(1):45-9. PubMed ID: 11293098
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Gabapentin as add-on therapy in focal epilepsy: a computerized EEG study.
    Mattia D; Spanedda F; Bassetti MA; Romigi A; Placidi F; Marciani MG
    Clin Neurophysiol; 2000 Feb; 111(2):311-7. PubMed ID: 10680567
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long-term treatment with gabapentin for partial epilepsy.
    Ojemann LM; Wilensky AJ; Temkin NR; Chmelir T; Ricker BA; Wallace J
    Epilepsy Res; 1992 Nov; 13(2):159-65. PubMed ID: 1464301
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lack of interaction of gabapentin with carbamazepine or valproate.
    Radulovic LL; Wilder BJ; Leppik IE; Bockbrader HN; Chang T; Posvar EL; Sedman AJ; Uthman BM; Erdman GR
    Epilepsia; 1994; 35(1):155-61. PubMed ID: 8112239
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Monotherapy using gabapentin in epilepsy].
    Sancho-Rieger J; López-Trigo J
    Rev Neurol; 2002 Feb 1-15; 34(3):290-2. PubMed ID: 12022083
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Gabapentin add-on therapy with adaptable dosages in 610 patients with partial epilepsy: an open, observational study. The French Gabapentin Collaborative Group.
    Baulac M; Cavalcanti D; Semah F; Arzimanoglou A; Portal JJ
    Seizure; 1998 Feb; 7(1):55-62. PubMed ID: 9548227
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The long-term use of gabapentin, lamotrigine, and vigabatrin in patients with chronic epilepsy.
    Wong IC; Chadwick DW; Fenwick PB; Mawer GE; Sander JW
    Epilepsia; 1999 Oct; 40(10):1439-45. PubMed ID: 10528941
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dosing to efficacy with neurontin: the STEPS trial. Study of Titration to Effect Profile of Safety.
    Morrell MJ
    Epilepsia; 1999; 40 Suppl 6():S23-6; discussion S73-4. PubMed ID: 10530679
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficacy of gabapentin therapy in children with refractory partial seizures.
    Khurana DS; Riviello J; Helmers S; Holmes G; Anderson J; Mikati MA
    J Pediatr; 1996 Jun; 128(6):829-33. PubMed ID: 8648543
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Gabapentin as adjuvant therapy in the treatment of refractory partial epilepsy].
    Tomović M; Ilić T; Mihajlović M; Jovicić A
    Vojnosanit Pregl; 1999; 56(2):151-6. PubMed ID: 10437420
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A beneficial effect on mood in partial epilepsy patients treated with gabapentin.
    Harden CL; Lazar LM; Pick LH; Nikolov B; Goldstein MA; Carson D; Ravdin LD; Kocsis JH; Labar DR
    Epilepsia; 1999 Aug; 40(8):1129-34. PubMed ID: 10448827
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Gabapentin for drug-resistant partial epilepsy.
    Marson AG; Kadir ZA; Hutton JL; Chadwick DW
    Cochrane Database Syst Rev; 2000; (2):CD001415. PubMed ID: 10796785
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Gabapentin associated with aggressive behavior in pediatric patients with seizures.
    Tallian KB; Nahata MC; Lo W; Tsao CY
    Epilepsia; 1996 May; 37(5):501-2. PubMed ID: 8617181
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy and safety of gabapentin as an add-on therapy in refractory partial epileptic patients.
    Towanabut S; Rungreangyingyod L; Suthisisang C
    J Med Assoc Thai; 2001 Apr; 84(4):554-61. PubMed ID: 11460968
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gabapentin in the management of convulsive disorders.
    McLean MJ
    Epilepsia; 1999; 40 Suppl 6():S39-50; discussion S73-4. PubMed ID: 10530682
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Long-term retention rates of lamotrigine, gabapentin, and topiramate in chronic epilepsy.
    Lhatoo SD; Wong IC; Polizzi G; Sander JW
    Epilepsia; 2000 Dec; 41(12):1592-6. PubMed ID: 11114218
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Gabapentin in generalized seizures.
    Chadwick D; Leiderman DB; Sauermann W; Alexander J; Garofalo E
    Epilepsy Res; 1996 Nov; 25(3):191-7. PubMed ID: 8956916
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Serum concentrations and effects of gabapentin and vigabatrin: observations from a dose titration study.
    Lindberger M; Luhr O; Johannessen SI; Larsson S; Tomson T
    Ther Drug Monit; 2003 Aug; 25(4):457-62. PubMed ID: 12883229
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of gabapentin on the anticonvulsant activity of antiepileptic drugs against electroconvulsions in mice: an isobolographic analysis.
    Borowicz KK; Swiader M; Luszczki J; Czuczwar SJ
    Epilepsia; 2002 Sep; 43(9):956-63. PubMed ID: 12199720
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Plasma gabapentin concentrations in children with epilepsy: influence of age, relationship with dosage, and preliminary observations on correlation with clinical response.
    Gatti G; Ferrari AR; Guerrini R; Bonanni P; Bonomi I; Perucca E
    Ther Drug Monit; 2003 Feb; 25(1):54-60. PubMed ID: 12548145
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.